生物学奖得主：法国的Marie-Christine Cadiergues Christel Joubert and Michel Franc获奖原因：发现狗身上的跳蚤比猫身上的跳蚤跳得更高。这项研究商业价值巨大－－对于跳蚤马戏团来说。医学奖得主： 美国杜克大学的Dan Ariely <http://www.predictablyirrational.com/> 、麻省理工的Rebecca L. Waber <http://www.innosight.co ...

12 月份「医学时间」答题挑战赛已落幕！获奖名单如下：12 月份「世界排名」学霸学神获奖名单（礼品任君选哦，戳这里）：正确率最高（丁香园 ID) 答题数最多（丁香园 ID）智多星 961q520lmuchunjvmanmanleleyupfwyyw1还有以下 15 名幸运用户获得马克杯一枚

在「轻松开诊所」的社群内，在诊所运营直播课中，很多医生创业者都提到一个很重要的问题：诊所该如何留住人才？今天小助手为大家献上 12 招，教你轻松留住好人...的人员是合乎诊所需要的「合适人才」。12 、优秀人才回流机制让离职人才再次回到诊所，可以带来诸多益处：1）可以大大节省人力成本；2）可以在员工心目中树立企业

！肺功能和呼吸力学PaCO2= k×[VCO2/VE（1-VD/VT）]k：常数；VCO2：CO2生成量；VE：分钟通气量；PaCO2：动脉血 CO2分压FiO2为吸入氧浓度；PB 为大气压；47 为呼吸道饱和水蒸气压（mmHg）；R 为呼吸商，通常为 0.8。肺泡-动脉血氧分压差 [P

！肺功能和呼吸力学PaCO2= k×[VCO2/VE（1-VD/VT）]k：常数；VCO2：CO2生成量；VE：分钟通气量；PaCO2：动脉血 CO2分压FiO2...）=(PaCO2- PetCO2)/ PaCO2VD：死腔量；VT：潮气量；PetCO2：呼气末 CO2分压；PaCO2：动脉血 CO2分压肺顺应性 = 潮气量（VT

不准这样的问题。12.学术欺诈：经过研究者编造或者篡改的研究结果，没有人能够重复出来。不过，在那些不可能重复的研究中，因为学术欺诈所导致的只占很少的

呼吸内镜下的介入治疗已成为气道和肺部疾病必不可少的诊治手段，目前许多医院已开展这方面的工作。近年来煤炭总医院致力于复杂、疑难气道病变的诊治，已开展万余例气管镜介入治疗手术，在氩等离子体凝固、CO2冷冻、内支架置入及取出、放射性粒子植入、硬质镜、胸腔镜等方面积累的了丰富经验，并已连续主办了六届气管镜介入治疗

有限责任公司 Reed Sinopharm Exhibitions Co., Ltd支持单位：美国

, 等. 不同体位和不同压力的 CO2 气腹对腹腔镜手术患者下肢深静脉血流动力学的影响 [J]. 中华胃肠外科杂志, 2009,12(4): 361-363....过大，尤其是腹膜切口过大；或由于手术复杂，操作时间较长，频繁更换器械、拔出戳卡。4. 手术操作空间内注入的 CO2 压力过高，手术时间过长。预防措施

】：1.Integrated Development Associates Co., Ltd（CRO）;2. IBM国际商业机器（中国）有限公司（AI）;3. 北京春天医药...(CRO)11. 缔脉生物医药科技（上海）有限公司（CRO）；12. 上海优宁维生物科技股份有限公司（其他-抗体服务商）；13杭州泰格医药科技股份有限公司（CRO

, co-sponsored by IEEE Tainan Section, Huazhong University of Science and Technology... accept our apology.2011年ICBMI会议将于12月14日至17日在中国湖北武汉华中科技大学举办，会议由IEEE台湾

2011年美国迈阿密国际医疗器械展（FIME 2011）展会时间：2011年08月10日～12日... Exit & Entry Co.,Ltd邱先生 Mr. andy-ku电话

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer

专题研讨12：糖尿病的管理和教育时间：2007 年11 月17 日09:50-11:30地点：第八会场主持人：郭晓蕙 孙子林09:50-10:20专题报告：The history and process for CDE accreditationDonna M. Rice American

记者从太原市卫计委获悉，11 月 1 日起，太原市 12 所市级公立医院将取消药品加成（中药饮片除外），实行零差率销售，也就是所有药品将按进价出售，减轻患者...突破口，决定从 11 月 1 日起，对 12 所市级公立医院取消药品加成。医院由此减少的合理收入，将通过财政补助 15%，部分医疗服务价格调整补偿 80%，医院

我们一起来回顾下 12 月发表在 JCO 的研究。（点击每个标题都可查看原文）快速通讯癌症基因检测乳腺癌或卵巢癌女性的基因检测：美国只有不到 1/5 应行... 名二线以上治疗的复发难治性惰性淋巴瘤患者接受 Copanlisib 60 mg iv d1,8,15,28 天一周期治疗，ORR 59%，12% 患者达到 CR